type here...

CATEGORIES

Press Release

LATEST

1...789...12Page 8 of 12

TRENDING

EDITORS CHOICE

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

The Diversion of Drugs Within Healthcare Needs to be Addressed

Medika Life -
The Protenus Drug Diversion Digest found that over half of diversion incidents took place in a hospital, medical center, or physician practice setting

FINN Adds Medika Life to its Omni-Channel Communications Platform

Medika Life -
FINN Partners adds Medika Life to it's Omni-Channel Health Platform, Gill Bashe to assume role of Editor in Chief as Medika strives to continue it founding goals.

An Unexpected Role for the Brain’s Immune Cells

Medika Life -
An important part of the brain's immune system, cells called microglia constantly extend and retract "branches" from their cell body to survey their environment.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories